Global ETD Search
Search theses and dissertations gathered from participating repositories worldwide. Every result links back to the library that holds it. No account is needed.
Results
Showing 1 to 20 of 92 for “"hyperhomocysteinemia"”.
-
Recurrent miscarriage and hyperhomocysteinemia
Contains fulltext : mmubn000001_21747554x.pdf (Publisher’s version ) (Open Access)
-
Recurrent miscarriage and hyperhomocysteinemia
Item does not contain fulltext
-
Molecular genetic analysis of hyperhomocysteinemia.
Homocysteine is a intermediary product of protein metabolism. A high concentration of homocysteine in the blood is associated with a higher risk of cardiovascular disease, including venous thrombosis. Homocysteine levels are in part determined by genetic factors and vitamin intake (such as vitamin …
-
Molecular genetic analysis in hyperhomocysteinemia
Katholieke Universiteit Nijmegen, 21 april 1998
-
Genetics of hyperhomocysteinemia in vascular disease
UMC St Radboud, 06 november 2002
-
Genetics of hyperhomocysteinemia in vascular disease
Item does not contain fulltext
-
Hyperhomocysteinemia: inherited causes and effects of treatment
Contains fulltext : mmubn000001_235021652.pdf (Publisher’s version ) (Open Access)
-
Epigenetic modifications associated with aortic remodeling in hyperhomocysteinemia.
Background: Hyperhomocysteinemia (HHcy) is prevalent in hypertensive patients and is an independent risk factor for aortic pathologies. HHcy is known to cause an imbalance between matrix metalloproteinases (MMPs) and tissue inhibitors of metalloproteinases (TIMPs) leading to accumulation of …
-
EFFECT AND MECHANISM OF HYPERHOMOCYSTEINEMIA ON ENDOTHELIAL INSULIN SIGNALING
Hyperhomocysteinemia (HHcy) is an independent risk factor for cardiovascular disease (CVD). Both HHcy and insulin resistance (IR) are associated with atherosclerotic CVD. Recent studies have confirmed that insulin is not only a principle regulator of glucose homeostasis but also an important …
-
Hyperhomocysteinemia and Inflammatory Profile in the Central Nervous System
… activation. Our studies sought to determine if hyperhomocysteinemia affects cell infiltrates in the Central Nervous System (CNS). Inflammatory monocytes recruitment into the CNS and microglia proliferation have been shown in several inflammatory models, and Ly-6Chi CCR2+ monocytes have been …
-
Toll-like receptor 4 mutation suppresses hyperhomocysteinemia-mediated hypertension.
Background: Hyperhomocysteinemia (HHcy) has been observed to promote hypertension, but the mechanisms are unclear. Toll-like receptor 4 (TLR-4) is a cellular membrane protein that is ubiquitously expressed in all cell types of the vasculature. TLR-4 activation has been shown to promote inflammation …
-
Exercise prevents hyperhomocysteinemia in a folate-deficient mouse model
… disease, neural tube defects, and cancer. Hyperhomocysteinemia is a condition that occurs when blood plasma concentrations of homocysteine exceed 15μM and has been implicated as an independent risk factor in cardiovascular disease. Specifically, populations with genetic polymorphisms in …
-
EVALUATING THE ROLE OF MMP9 IN HYPERHOMOCYSTEINEMIA INDUCED CEREBROVASCULAR PATHOLOGY
… of AD. Elevated plasma homocysteine, known as hyperhomocysteinemia (HHcy), is a risk factor for VCID; however, the mechanism underlying the connection between HHcy and development of VCID pathology remains elusive. Understanding this mechanism would reveal novel therapeutic targets with the …
-
Effects of hydrogen sulfide in hyperhomocysteinemia-mediated skeletal muscle myopathy.
Although hyperhomocysteinemia (HHcy) occurs due to a deficiency in cystathionine-β-synthase (CBS), causing skeletal muscle myopathy, it is still unclear whether this effect is mediated through oxidative, endoplasmic reticulum (ER) stress, both or something else. Cystathionine γ-lyase (CSE) and CBS …
-
Redox Triggering of Podocyte NLRP3 Inflammasomes and Glomerular Injury in Hyperhomocysteinemia
Hyperhomocysteinemia (hHcys), an important pathogenic factor contributing to the progression of end-stage renal disease (ESRD), has been shown to activate NOD-like receptor protein 3 (NLRP3) inflammasomes and cause podocyte dysfunction and glomerular sclerosis. hHcys induces aggregation of the …
-
Exercise mitigates the effects of hyperhomocysteinemia on adverse skeletal muscle remodeling.
Background: Hyperhomocysteinemia (HHcy) is heavily implicated in diabetes and cardiovascular disease. HHcy is known for causing inflammation and vascular remodeling, particularly through production of reactive oxygen species (ROS) and matrix metalloproteinase-9 (MMP-9). Although its impact on …
-
HYPERHOMOCYSTEINEMIA ACCELERATES THROMBOSIS THROUGH ICAM-1 DEPENDENT ENDOTHELIAL ACTIVATION AND DNA HYPOMETHYLATION
Background: Hyperhomocysteinemia (HHcy) is an established risk factor for thrombotic diseases yet the underlying mechanism remain unclear. In this study we investigated the effect of HHcy on endothelial cell-platelet interaction and its role in thrombosis. Methods and Results: We used a novel mouse …
-
Role of Vav2 in Podocyte Inflammasome Activation and Glomerular Injury During Hyperhomocysteinemia
Hyperhomocysteinemia (hHcys) is a widely known pathogenic factor in the progression of end-stage renal disease (ESRD) and it is also associated with an increased risk for injurious cardiovascular pathologies during ESRD. HHcys is linked to the formation and activation of the NOD-like receptor …
-
HYPERHOMOCYSTEINEMIA ACCELERATES ATHEROSCLEROSIS BY INDUCING INFLAMMATORY MONOCYTE DIFFERENTIATION IN A HYPERGLYCEMIC MOUSE MODEL
… of studies have revealed an association between hyperhomocysteinemia (HHcy), in which plasma Hcy levels exceed 15 µM, and diabetic atherosclerosis [1]. Despite these associations, the mechanisms underlying HHcy - associated diabetic atherosclerosis have not been clearly defined. This study …
-
Hyperhomocysteinemia alters sinoatrial and atrioventricular nodal function : role of the cardiac NMDA receptor.
Introduction: Hyperhomocysteinemia (HHcy) is a pathological condition characterized by excessive levels of plasma homocysteine (Hcy). Patients with HHcy are reported to be at risk for arrhythmias like atrial fibrillation and sudden cardiac death (SCD); however, the causative mechanisms remain …
Page 1 of 5